117 related articles for article (PubMed ID: 8058059)
1. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation.
Ben-Baruch N; Reinhold WC; Alexandrova N; Ichinose I; Blake M; Trepel JB; Zajac-Kaye M
Mol Pharmacol; 1994 Jul; 46(1):73-8. PubMed ID: 8058059
[TBL] [Abstract][Full Text] [Related]
2. c-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine.
Yen A; Forbes ME
Cancer Res; 1990 Mar; 50(5):1411-20. PubMed ID: 2302706
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of TRRAP-dependent hTERT and TRRAP-independent CAD activation by Myc/Max contributes to the differentiation of HL60 cells after exposure to DMSO.
Jiang G; Bi K; Tang T; Wang J; Zhang Y; Zhang W; Ren H; Bai H; Wang Y
Int Immunopharmacol; 2006 Jul; 6(7):1204-13. PubMed ID: 16714225
[TBL] [Abstract][Full Text] [Related]
4. Changes in c-myc, c-fms, and N-ras proto-oncogene expression associated with retinoic acid-induced monocytic differentiation of human leukemia HL60/MRI cells.
Imaizumi M; Breitman TR
Cancer Res; 1988 Dec; 48(23):6733-8. PubMed ID: 3180083
[TBL] [Abstract][Full Text] [Related]
5. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
6. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
[TBL] [Abstract][Full Text] [Related]
7. Different regulation of N- and c-myc expression during phorbol ester-induced maturation of human SH-SY5Y neuroblastoma cells.
Hammerling U; Bjelfman C; Påhlman S
Oncogene; 1987; 2(1):73-7. PubMed ID: 3325885
[TBL] [Abstract][Full Text] [Related]
8. A transactivator of c-myc is coordinately regulated with the proto-oncogene during cellular growth.
Bazar L; Harris V; Sunitha I; Hartmann D; Avigan M
Oncogene; 1995 Jun; 10(11):2229-38. PubMed ID: 7784068
[TBL] [Abstract][Full Text] [Related]
9. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
Curran T; Bravo R; Müller R
Cancer Surv; 1985; 4(4):655-81. PubMed ID: 3939686
[TBL] [Abstract][Full Text] [Related]
10. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
Blagosklonny MV; Prabhu NS; El-Deiry WS
Cancer Res; 1997 Jan; 57(2):320-5. PubMed ID: 9000576
[TBL] [Abstract][Full Text] [Related]
11. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc.
Larsson LG; Pettersson M; Oberg F; Nilsson K; Lüscher B
Oncogene; 1994 Apr; 9(4):1247-52. PubMed ID: 8134128
[TBL] [Abstract][Full Text] [Related]
12. Posttranscriptional regulation of colony-stimulating factor-1 (CSF-1) and CSF-1 receptor gene expression during inhibition of phorbol-ester-induced monocytic differentiation by dexamethasone and cyclosporin A: potential involvement of a destabilizing protein.
Chambers SK; Gilmore-Hebert M; Wang Y; Rodov S; Benz EJ; Kacinski BM
Exp Hematol; 1993 Sep; 21(10):1328-34. PubMed ID: 8359233
[TBL] [Abstract][Full Text] [Related]
13. Cell-cycle progression is not essential for c-Myc to block differentiation.
Ryan KM; Birnie GD
Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
[TBL] [Abstract][Full Text] [Related]
14. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of c-myc gene is not obligatory for growth inhibition and differentiation of human myeloid leukemia cells.
Gómez-Casares MT; Delgado MD; Lerga A; Crespo P; Quincoces AF; Richard C; León J
Leukemia; 1993 Nov; 7(11):1824-33. PubMed ID: 8231250
[TBL] [Abstract][Full Text] [Related]
16. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
17. c-myc gene inactivation during induction of nasopharyngeal carcinoma cells with retinoic acid.
Jiang N; Zhan F; Cao L; Yao K; Li G
Chin Med J (Engl); 2000 Sep; 113(9):823-6. PubMed ID: 11776079
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by oxysterol in CEM cells is associated with negative regulation of c-myc.
Ayala-Torres S; Zhou F; Thompson EB
Exp Cell Res; 1999 Jan; 246(1):193-202. PubMed ID: 9882528
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
20. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
